Benefits

• Life-science research in space to develop new drugs and vaccines
• Affordable microgravity research
• Fully autonomous mini-labs on satellite platforms
• Opportunity to share satellite research payloads.

Technology

Part of the company’s core technology is an advanced microfluidic chip integrated with a state-of-the-art electronic sensor suite and data acquisition system. These experiments allow the platform to understand and control the behavioural changes of microbes in spaces, as well as aiding in the development of new pharmaceutical products. ResearchSat provides an end-to-end service so that researchers can focus on the thing that matters the most - their experiments. Co-design: collaboration with the researcher to develop the microfluidic chip and sensor suite based on the needs of that particular experiment. Launch logistics: all logistics related to the launch, including regulatory requirements, insurance, and transportation will be taken care of. Results delivery: feedback of data, in near real-time, fully translated from the payload’s sensors, monitoring equipment and specimen delivery.

Potential markets

The platform is configurable to facilitate research across multiple industries, ranging from food (new food products), pharma (drug discovery/precision medication), agriculture (nutrient research) and biotech(next generation equipment).

Partnering opportunities

ResearchSat is looking to collaborate with research organisations, academic researchers and cubesat platforms who can host their payload. There is also a potential for partnerships with other cubesat companies to share launch costs. The company is aiming to launch their first payload into orbit by late 2020 and is actively seeking research and funding partners.